Literature DB >> 21959830

Blood flow change quantification in cervical cancer before and during radiation therapy using perfusion CT.

Kei Shibuya1, Yoshito Tsushima, Eri Horisoko, Shin-ei Noda, Ayako Taketomi-Takahashi, Tatsuya Ohno, Makoto Amanuma, Keigo Endo, Takashi Nakano.   

Abstract

The purpose of this study was to quantify the changes of tumor blood flow (BF) in cervical cancer after radiation therapy by using perfusion computed tomography (CT), and to examine the difference between maximum slope (MS) and single-input one-compartment model (SOCM) methods. Fourteen consecutive patients who received definitive radiation therapy for cervical cancer from October 2009 to February 2010 were enrolled in this study. Blood flow (BF) analyses were performed using both MS and SOCM methods. Quantitative BF maps were created using Body Perfusion (Toshiba Medical Systems, Co. Tokyo, Japan). Perfusion color maps were successfully created by the two analytical methods. BF of the tumors was clearly higher than that of normal cervix, making it possible to distinguish tumor tissue from normal cervical tissue. BF of the tumors after 20 Gy of radiation therapy calculated by the MS method was significantly larger than that before treatment (126.9 vs. 72.2 ml/min/100 ml, median; p < 0.05). Although BF calculated by the MS and SOCM methods showed a positive linear correlation (p < 0.001, r = 0.981), BF calculated by the MS method was lower than that obtained by the SOCM method (103.7 vs. 115.1 ml/min/100 ml, p < 0.01). The change of tumor BF in cervical cancer before and after radiation therapy can be monitored by conducting blood flow analysis using perfusion CT. BF by the MS method was lower than that by the SOCM method, but the two analytical methods correlated well. Perfusion CT may have potential in noninvasive monitoring of vascular and oxygenation status and for guiding adaptive therapy.

Entities:  

Mesh:

Year:  2011        PMID: 21959830     DOI: 10.1269/jrr.11079

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  9 in total

1.  Perfusion and diffusion characteristics of cervical cancer based on intraxovel incoherent motion MR imaging-a pilot study.

Authors:  Elaine Yuen Phin Lee; Xue Yu; Mandy Man Yee Chu; Hextan Yuen Sheung Ngan; Steven Wai Kwan Siu; Inda Sung Soong; Queenie Chan; Pek-Lan Khong
Journal:  Eur Radiol       Date:  2014-04-19       Impact factor: 5.315

2.  Use of patient outcome endpoints to identify the best functional CT imaging parameters in metastatic renal cell carcinoma patients.

Authors:  Jill Rachel Mains; Frede Donskov; Erik Morre Pedersen; Hans Henrik Torp Madsen; Jesper Thygesen; Kennet Thorup; Finn Rasmussen
Journal:  Br J Radiol       Date:  2018-01-02       Impact factor: 3.039

3.  Comparing CT perfusion with oxygen partial pressure in a rabbit VX2 soft-tissue tumor model.

Authors:  Chang-Jin Sun; Chao Li; Hai-Bo Lv; Cong Zhao; Jin-Ming Yu; Guang-Hui Wang; Yun-Xiu Luo; Yan Li; Mingyong Xiao; Jun Yin; Jin-Yi Lang
Journal:  J Radiat Res       Date:  2013-09-26       Impact factor: 2.724

4.  Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging.

Authors:  Li Zhu; Lijing Zhu; Hua Shi; Huanhuan Wang; Jing Yan; Baorui Liu; Weibo Chen; Jian He; Zhengyang Zhou; Xiaofeng Yang; Tian Liu
Journal:  BMC Cancer       Date:  2016-02-10       Impact factor: 4.430

Review 5.  The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future.

Authors:  Lisanne C Hamming; Ben J Slotman; Henk M W Verheul; Victor L Thijssen
Journal:  Angiogenesis       Date:  2017-03-31       Impact factor: 9.596

6.  Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect.

Authors:  Esther A Kleibeuker; Emmanouil Fokas; Philip D Allen; Veerle Kersemans; Arjan W Griffioen; John Beech; Jaehong H Im; Sean C Smart; Kitty C Castricum; Jaap van den Berg; Iris A Schulkens; Sally A Hill; Adrian L Harris; Ben J Slotman; Henk M Verheul; Ruth J Muschel; Victor L Thijssen
Journal:  Oncotarget       Date:  2016-11-22

Review 7.  Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?

Authors:  Ruben S A Goedegebuure; Leonie K de Klerk; Adam J Bass; Sarah Derks; Victor L J L Thijssen
Journal:  Front Immunol       Date:  2019-01-14       Impact factor: 7.561

8.  Endothelial cell death after ionizing radiation does not impair vascular structure in mouse tumor models.

Authors:  Ruth J Muschel; Bostjan Markelc; Jakob R Kaeppler; Jianzhou Chen; Mario Buono; Jenny Vermeer; Pavitra Kannan; Wei-Chen Cheng; Dimitrios Voukantsis; James M Thompson; Mark A Hill; Danny Allen; Ana Gomes; Veerle Kersemans; Paul Kinchesh; Sean Smart; Francesca Buffa; Claus Nerlov
Journal:  EMBO Rep       Date:  2022-07-18       Impact factor: 9.071

9.  Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response.

Authors:  Thomas I Banks; Rie von Eyben; Dimitre Hristov; Elizabeth A Kidd
Journal:  Cancer Med       Date:  2018-07-02       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.